help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamel, F. G.
Right arrow Articles by Duckworth, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamel, F. G.
Right arrow Articles by Duckworth, W. C.
Endocrinology Vol. 139, No. 10 4061-4066
Copyright © 1998 by The Endocrine Society

ARTICLES

Regulation of Multicatalytic Enzyme Activity by Insulin and the Insulin-Degrading Enzyme1

Frederick G. Hamel, Robert G. Bennett and William C. Duckworth

Veterans Affairs Medical Center, the Departments of Medicine and Pharmacology (F.G.H.) and Biochemistry and Molecular Biology (R.G.B., W.C.D.), University of Nebraska Medical Center, Omaha, Nebraska 68198-3020

Address all correspondence and requests for reprints to: William C. Duckworth, M.D., University of Nebraska Medical Center, 600 South 42nd Street, Omaha, Nebraska 68198-3020.

The insulin-degrading enzyme (IDE) plays an important role in the cellular metabolism of insulin. Recent studies have also suggested a regulatory role for this protein in controlling the activity of cytoplasmic protein complexes, including the proteasome [multicatalytic proteinase (MCP)] and the glucocorticoid and androgen receptors. Binding of IDE to these complexes increases their activity, whereas the addition of substrates for IDE inhibits activity. This provides a potential mechanism of action for internalized insulin and other IDE substrates in the control of protein turnover. To examine further the interactions, partially purified IDE-MCP complex was treated with EDTA or EGTA, and activity was measured in the absence and presence of various divalent cations (Ca2+, Mn2+, Co2+, and Zn2+) and insulin. EDTA treatment reduced MCP activity and eliminated the effect of insulin on the complex. Divalent cations partially or completely restored MCP activity, but did not restore the effect of insulin. EGTA treatment had a lesser effect on MCP activity, but abolished insulin inhibition of activity. Divalent cations restored the insulin effect. Inhibitors of IDE also blocked the insulin effect on MCP activity, as did treatment with SDS. These findings suggest that conformational changes in the complex may play a role in the insulin control of MCP activity.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
F. G. Hamel, J. L. Upward, and R. G. Bennett
In Vitro Inhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters
Endocrinology, June 1, 2003; 144(6): 2404 - 2408.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. V. Fleming and T. C. Wang
Amino- and Carboxy-Terminal PEST Domains Mediate Gastrin Stabilization of Rat L-Histidine Decarboxylase Isoforms
Mol. Cell. Biol., July 1, 2000; 20(13): 4932 - 4947.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
R. G. Bennett, F. G. Hamel, and W. C. Duckworth
Insulin Inhibits the Ubiquitin-Dependent Degrading Activity of the 26S Proteasome
Endocrinology, July 1, 2000; 141(7): 2508 - 2517.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society